P741: PATIENTS’ PERSPECTIVES ON ORAL DECITABINE AND CEDAZURIDINE FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES

Amer M. Zeidan, Kate Perepezko, Tehseen Salimi, Terri Washington, Robert Epstein

Open source

DOI
10.1097/01.hs9.0000969868.76739.08
Published
8
Container
HemaSphere
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/01.hs9.0000969868.76739.08,
  title = {P741: PATIENTS’ PERSPECTIVES ON ORAL DECITABINE AND CEDAZURIDINE FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES},
  author = {Amer M. Zeidan and Kate Perepezko and Tehseen Salimi and Terri Washington and Robert Epstein},
  year = {2023},
  journal = {HemaSphere},
  doi = {10.1097/01.hs9.0000969868.76739.08},
  url = {https://doi.org/10.1097/01.hs9.0000969868.76739.08}
}

RIS

TY  - JOUR
TI  - P741: PATIENTS’ PERSPECTIVES ON ORAL DECITABINE AND CEDAZURIDINE FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES
AU  - Amer M. Zeidan
AU  - Kate Perepezko
AU  - Tehseen Salimi
AU  - Terri Washington
AU  - Robert Epstein
PY  - 2023
JO  - HemaSphere
DO  - 10.1097/01.hs9.0000969868.76739.08
UR  - https://doi.org/10.1097/01.hs9.0000969868.76739.08
ER  - 

APA

Zeidan, A. M., Perepezko, K., Salimi, T., Washington, T., & Epstein, R. (2023). P741: PATIENTS’ PERSPECTIVES ON ORAL DECITABINE AND CEDAZURIDINE FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES. HemaSphere. https://doi.org/10.1097/01.hs9.0000969868.76739.08

Source records